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Abstract
Background: Novel methods to identify anthelmintic drug and vaccine targets are urgently needed, especially for those
parasite species currently being controlled by singular, often limited strategies. A clearer understanding of the
transcriptional components underpinning helminth development will enable identification of exploitable molecules
essential for successful parasite/host interactions. Towards this end, we present a combinatorial, bioinformatics-led
approach, employing both statistical and network analyses of transcriptomic data, for identifying new immunoprophylactic
and therapeutic lead targets to combat schistosomiasis.
Methodology/Principal Findings: Utilisation of a Schistosoma mansoni oligonucleotide DNA microarray consisting of 37,632
elements enabled gene expression profiling from 15 distinct parasite lifecycle stages, spanning three unique ecological
niches. Statistical approaches of data analysis revealed differential expression of 973 gene products that minimally describe
the three major characteristics of schistosome development: asexual processes within intermediate snail hosts, sexual
maturation within definitive vertebrate hosts and sexual dimorphism amongst adult male and female worms. Furthermore,
we identified a group of 338 constitutively expressed schistosome gene products (including 41 transcripts sharing no
sequence similarity outside the Platyhelminthes), which are likely to be essential for schistosome lifecycle progression. While
highly informative, statistics-led bioinformatics mining of the transcriptional dataset has limitations, including the inability
to identify higher order relationships between differentially expressed transcripts and lifecycle stages. Network analysis,
coupled to Gene Ontology enrichment investigations, facilitated a re-examination of the dataset and identified 387 clusters
(containing 12,132 gene products) displaying novel examples of developmentally regulated classes (including 294
schistosomula and/or adult transcripts with no known sequence similarity outside the Platyhelminthes), which were
undetectable by the statistical comparisons.
Conclusions/Significance: Collectively, statistical and network-based exploratory analyses of transcriptomic datasets have
led to a thorough characterisation of schistosome development. Information obtained from these experiments highlighted
key transcriptional programs associated with lifecycle progression and identified numerous anti-schistosomal candidate
molecules including G-protein coupled receptors, tetraspanins, Dyp-type peroxidases, fucosyltransferases, leishmanolysins
and the netrin/netrin receptor complex.
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Introduction
Parasitic helminths constitute the most important group of
metazoan pathogens affecting the global health and wellbeing of
human and animal populations. While most infected individuals
live within subtropical and tropical countries of the developing
world, distribution of favourable habitats for helminth transmis-
sion will likely expand considering the prediction of a worldwide
temperature increase between 1.1uC–6.4uC in the 21st century [1].
Worryingly, existing control strategies are extremely restricted; the
main weapon being limited anthelmintics to treat infected
individuals therapeutically. Additionally, there are no commercial
vaccines available to combat infection prophylactically and the
general community consensus is that no current experimental
vaccine will be available for widespread use in the foreseeable
future [2].
Despite these disturbing trends and problematic issues, recent
genomic and transcriptomic characterisation of several nematode
and platyhelminth species have provided the necessary resources
for post-genomic technologies to make positive strides in the
identification of novel anthelmintic targets [3,4,5,6]. In the
research field of schistosomiasis, a disease that kills 200,000
individuals/annum [7], elucidation of the expressed genome
complement [4,5], assembly and annotation of first pass genomes
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[8,9], multiple descriptions of targeted proteome, glycome and
differential transcriptomes [10,11] and the utilisation of post-
transcriptional gene silencing (PTGS) [12] have all contributed to
a much greater understanding of the causative parasite’s biology.
Collectively, this information has vastly accelerated our ability to
identify and prioritise next generation drug and vaccine targets.
A potential bottleneck in exploiting this knowledge for schisto-
somiasis control, however, relates to the complexity of the
schistosome’s digenetic and dioecious lifecycle. As the parasite
alternates between three environmental niches (freshwater, inter-
mediate molluscan and definitive vertebrate hosts) and undergoes
two distinct types of reproductive processes (asexual and sexual), it is
experimentally difficult to identify when and where all of the 13,000
gene products are expressed [8,9]. However, categorisation of the
expressed genome complement during schistosome development
has recently been conducted in a few high-throughput DNA
microarray studies [13,14,15]. While generally informative, these
studies were, nevertheless, limited by insufficient surveying of
lifecycle stages, use of restricted DNA microarrays or utilisation of
traditional statistical analyses not adjusted for false discovery rates.
Improvements in the methodology used for analysing DNA
microarray data as well as profiling larger numbers of schistosome
life-stages will ultimately provide a more detailed interpretation of
parasite developmental biology useful for target identification.
Towards this end, we describe the combined use of a 37,632
element long-oligonucleotide DNA microarray [16], pairwise
statistical comparisons and network theory analyses [17] to
thoroughly characterise the progression of schistosome development
spanning intra-molluscan- (mother sporocyst, daughter sporocyst),
aquatic-dwelling- (egg, cercariae and miracidia) and intra-verte-
brate- (egg, 3-hr, 24-hr, 3-day, 6-day, 2-wk, 3-wk, 5-wk, 7-wk, adult
males and adult females) lifecycle stages.
It is clear from this study that combined statistical and network-
based data analyses provide greater characterisation of schistosome
developmental processes than employing either single approach
alone. Using this information, we thoroughly describe the tran-
scriptional profiles associated with the dioecious and digenetic state,
detail multiple subsets of stage-specific transcripts, identify a cohort
of constitutively expressed gene products and report that the egg
and daughter sporocyst life-stages display highly divergent tran-
scriptional profiles. Furthermore, we demonstrate the added value
in simultaneously comparing the developmental expression profiles
of selected gene family members described as the next generation
vaccine candidates (the tetraspanins [18]), drug targets (G-protein
coupled receptors [19]) or enzymes involved in producing
immunomodulatory epitopes (fucosyltransferases [20]). Finally, we
illustrate how global gene expression profiles can provide vital
developmental information related to transcripts that have no
known sequence similarity outside of the phylum Platyhelminthes,
and thus, may represent new classes of anthelmintic targets.
Methods
Parasite material
A Puerto Rican strain of S. mansoni was used in this study. All
procedures performed on mice adhered to the United Kingdom
Home Office Animals (Scientific Procedures) Act of 1986 and were
approved by Aberystwyth University’s ethical review panel (ERP).
Mixed-sex worms (including gender-separated, mature adult male
and female worms) were perfused from percutaneously infected TO
(Tuck Ordinary) mice (Harlan, UK) challenged 2-, 3-, 5- or 7-weeks
earlier with 250 cercariae [21]. Eggs were recovered from mouse
livers of animals infected 7-weeks prior with cercariae as previously
described [21]. Cercariae were shed from Biomphalaria glabrata
intermediate snail hosts. Schistosomula were prepared by mechan-
ical transformation [21] and cultured at 37uC in DMEM (Sigma,
UK) supplemented with 10% foetal calf serum, 2 mM L-glutamine,
and 100 mg/ml penicillin/streptomycin in an atmosphere of 5%
CO2 for the timeframe indicated (3 hr, 24 hr, 3-day, 6-day).
Miracidia were hatched from S. mansoni eggs harvested from TO
mouse livers seven weeks after infection. Mother (2-day) sporocysts
were obtained by in vitro transformation of isolated miracidia [22],
while daughter sporocysts were derived from 15-day infected
B. glabrata snails [23].
Genomic DNA isolation
S. mansoni genomic DNA (gDNA) was prepared from mixed-sex
cercariae using a commercially available kit (DNeasy Tissue Kit,
Qiagen UK). All gDNA was qualitatively assessed by agarose gel
electrophoresis and quantitatively measured using a NanoDrop
ND-1000 UV-Vis spectrophotometer.
Total RNA isolation
S. mansoni total RNA was isolated as previously described [24].
Isolated total RNA was treated with DNAse I (Ambion UK) to
ensure RNA free from gDNA contamination. All RNA was
subsequently quantified with a NanoDrop ND-1000 UV-Vis
spectrophotometer and visualized for quality using an Agilent
2100 bioanalyzer.
Construction of long oligonucleotide DNA microarray
The S. mansoni long oligonucleotide DNA microarray was
designed and constructed as reported in Fitzpatrick et al. [16].
Briefly, the DNA microarray consists of 37,632 elements; 35,437 S.
mansoni oligonucleotide 50-mers and 2,195 controls. The micro-
array is deposited in the ArrayExpress (European Bioinformatics
Institute, Hinxton UK) database under the accession number A-
MEXP-830 and is available from the Centre for Microarray
Author Summary
Despite the implementation of focused and well-funded
chemotherapeutic control initiatives over the last decade,
schistosomiasis remains a significant cause of morbidity
and mortality within countries of the developing world.
There is, therefore, an urgent need for the rapid translation
of genomic information into viable vaccines or new drug
classes capable of eradicating the parasitic schistosome
worms responsible for this neglected tropical disease. In
our effort to identify potential targets for novel chemo-
therapeutic and immunoprophylactic interventions, we
detail a combined bioinformatics approach, comprising
exploratory statistical and network analyses, to thoroughly
describe the transcriptional progression of Schistosoma
mansoni across three environmental niches. Our results
indicate that, although schistosomes are masters at host
deception and survival, there are numerous exploitable
candidate molecules displaying either differential or
constitutive expression throughout the parasite’s lifecycle.
Importantly, some of these transcripts represent gene
families not commonly found outside—or expanded
within—the phylum Platyhelminthes, and thus represent
priority targets. Many of the candidates identified herein
will be subjected to ongoing and future hypothesis-led
functional investigations. The completion of such specific
examinations ultimately will contribute to the successful
development of novel control strategies useful in the
alleviation of schistosome-induced immunopathologies,
morbidities and mortalities.
Schistosoma Transcriptional Profiling
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Resources, University of Cambridge UK. Sequences of each
oligonucleotide 50-mer and positions of stringent alignment on the
S. mansoni genome can be visualized using the S. mansoni genome
browser at GeneDB [25]. All clustered parent sequences used for
oligonucleotide design can be found in Dataset S1.
DNA microarray hybridization
AlexaFluor647-dCTP (AF647 - Amersham Biosciences UK)
labeled cDNA targets were generated through a modified version of
the procedure first described by Petalidis et al. [26]. These cDNA
targets were co-hybridised to the S. mansoni long-oligonucleotide
DNA microarray with a reference gDNA sample, labeled with
AlexaFluor555-dCTP (AF555) as previously described [16]. Image
acquisition (16-bit tiff) for the DNAmicroarray was performed using
a GenePixH 4100A (Axon Instruments Inc.) dual channel laser
scanner at 10 mm resolution, 100% laser power and photomultiplier
tube gain levels ranging from 730 to 870. BlueFuse for Microarrays
(BlueGnome Ltd., UK) image analysis software was employed to
extract fluorescent signal intensity data.
DNA microarray data analysis
‘Universal Timepoint Codes’ were assigned to the lifecycle stages
as follows: egg UT01, miracidia UT02, mother (2-day) sporocysts
UT03, daughter sporocysts UT04, cercariae UT05, 3-hr somules
UT06, 24-hr somules UT07, 3-day somules UT08, 6-day somules
UT09, 2-wk worms UT10, 3-wk worms UT11, 5-wk worms UT12,
mixed-sex 7-wk worms UT13, male 7-wk worms UT14, female
7-wk worms UT15.
Array data, normalised within each microarray to correct for
local background (print tip loess normalisation), were subsequently
normalised across all arrays using quantile normalisation with the
reference channel (gDNA; AF555). The log2 values of the AF647
channel data (non-control features only) were then extracted for
further analysis. All microarray data are MIAME compliant [27]
and a full (including controls) set of raw and normalised data is
available via ArrayExpress [28] under the experiment accession
number E-MEXP-2094.
Statistical analysis of DNA microarray data
Normalised log2 AF647 intensities for all DNA microarray
elements (minus negative controls) available for all 15 lifecycle
stages were linear model fitted using 3 replicates/lifecycle stage
(except for the adult female lifecycle stage where one replicate was
manually excluded). The Student’s t-test incorporating a Benja-
mini & Hochberg p-value adjustment (for multiple testing; the
adjusted p-value controls for false discovery rate) was used to
identify statistically significant differences in gene expression
between any compared life-stage. Log odds (B values) were also
calculated; transcripts having B values .0 are more likely to be
differentially expressed than not differentially expressed in any
pairwise comparison (full list of comparisons included in Table 1,
Dataset S2 and Dataset S3).
Table 1. Pairwise comparisons of key schistosome developmental stages reveal a number of differentially expressed genes.
Numbers of differentially expressed transcripts identified between indicated pair wise comparisona
Life-stage comparison p,0.05 p,0.01 p,0.001 p,0.0001 Adjp,0.05b Adjp,0.01b B$0c
Miracidium/Egg 3990 1677 444 67 48 0 219
Mother Sporocyst/Miracidium 147 48 9 4 1 0 0
Daughter Sporocyst/Mother Sporocyst 1971 378 53 14 4 2 11
Cercariae/Daughter Sporocyst 2353 680 202 87 103 47 141
Cercariae/Miracidium 860 462 223 137 166 98 186
3-Hr Schistosomulum/Cercariae 159 30 4 0 0 0 0
24-Hr Schistosomulum/Cercariae 321 111 27 5 0 0 0
3-Day Schistosomulum/Cercariae 308 120 48 14 2 0 0
6-Day Schistosomulum/Cercariae 457 179 74 29 17 6 23
24-Hr Schistosomulum/3-Hr Schistosomulum 141 37 2 1 0 0 0
3-Day Schistosomulum/24-Hr Schistosomulum 40 14 4 1 0 0 0
6-Day Schistosomulum/3-Day Schistosomulum 65 9 2 0 0 0 0
2-Wk Worm/6-Day Schistosomulum 1728 411 62 18 8 2 23
3-Wk Worm/2-Wk Worm 3599 940 94 4 0 0 23
Intra-snail stages/Intra-mouse stagesd 2608 1405 832 570 866 628 703
5-Wk Worm/3-Wk Worm 472 136 72 38 26 11 37
7-Wk Worm/5-Wk Worm 1119 219 17 3 0 0 0
7-Wk Worm/3-Wk Worm 274 134 82 47 41 16 52
7-Wk Female Worm/7-Wk Male Worm 609 209 85 43 31 5 58
(a) Pair wise comparisons represent the normalised log2 gene expression ratios for a gene in life stage ‘x’ relative to the same gene in sample ‘y’. (b) Adjusted p values
(Adjp) are derived from Benjamini & Hochberg correction method (). (c) B represents natural log odds of p (transcript is differentially expressed)/p (transcript is not
differentially expressed) and indicates those transcripts more likely to be differentially expressed than not (B$0). (d) Intra-snail stages/Intra-mouse stage comparisons
represent those genes that are differentially expressed as detected by the following formula: log2 gene expression ratios of (Miracidium + Daughter sporocyst + Mother
Sporocyst + Cercariae)/4 compared to log2 gene expression ratios of (3-Hr schistosomules +24-Hr schistosomules +3-Day schistosomules +6-Day schistosomules +2-Wk
worms +3-Wk worms +5-Wk worms +7-Wk worms +7-Wk Male worms +7-Wk Female worms/10). A top-table list containing these identified gene products is provided
in Dataset S2.
doi:10.1371/journal.pntd.0000543.t001
Schistosoma Transcriptional Profiling
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Heat maps displaying expression data were generated by
Empirical Bayesian analysis of the normalised AF647 values
(Dataset S4). LogFC (fold change) was also calculated in some
instances. Here, the logFC is the difference in log2 intensities for
each of the array features between two different lifecycle stages (i.e.
UT02-UT01 for gene X = log2intensity (UT02, gene X) –
log2intensity (UT01, gene X)).
Those transcripts that exhibited the lowest 1% variation in log2
AF647 intensities across the entire lifecycle were identified as
constitutively expressed gene products (Dataset S5).
Network analysis
A data matrix of normalised, de-logged, intensity values for all
genes across all microarrays was generated (Dataset S4). The
Pearson correlation between every object (a single gene’s normalised
AF647 intensity values across all arrays) and every other object in
that matrix was subsequently determined by Biolayout Express 3D
[29], effectively calculating the similarity in the profile of expression
of every gene on the DNA microarray across the samples analysed,
to every other gene on the DNAmicroarray. All relationships above
a Pearson correlation cut off of r = 0.94 were stored. The stored data
were used to draw the edges (lines) between nodes (transcripts) in
network graphs. Nodes sharing edges (relationships above the set
threshold) form into groups (graph components). Connectivity
between nodes determines the 3-dimensional layout of the graphs.
Using a Pearson correlation cut off (r = 0.94), 16,621 nodes formed
graph components.
Large graphs were further subdivided into groups or clusters of
nodes using a Markov Cluster algorithm (MCL). MCL clusters
included transcripts that were statistically differentially expressed
across groups (i.e. Adjp-value ,0.05) as well as those that,
although exhibiting similar profiles, were not statistically signifi-
cant. This type of analysis therefore allows for statistical
associations to be verified, but also is capable of identifying
associations which statistical analyses (on minimally replicated
datasets) may have not been able to detect. MCL clustering
applied to this dataset at a stringency of 1.7 was able to identify
387 clusters of 6 or more nodes (i.e. 12,132 nodes or 73% of the
original dataset, Dataset S6).
Gene Ontology (GO) analysis
A file containing all GO terms mapped to the S. mansoni gene
models in GeneDB [25] was generated for analysis. To identify
GO terms across all three categories (biological process, molecular
function or cellular composition) that were enriched in the
constitutively expressed gene list (Dataset S5), a hypergeometric
test was performed. GO terms having a hypergeometric p-value
,0.01 were considered enriched in the constitutive expressed gene
products.
GO enrichment analysis of MCL cluster members was also
performed, but was necessarily restricted to those with one or
more Smp loci (as GO terms were mapped to Smp loci) and was
not directional (i.e. could not be done separately for ‘‘up’’ and
‘‘down’’ regulated genes). As performed for the GO enrichment
analysis of the constitutively expressed gene products, a hypergeo-
metric enrichment p-value ,0.01 was applied (Dataset S6).
Gene family analysis
Three gene families were selected for detailed analysis. Nucleic
acid sequences corresponding to the tetraspanins (PF00335), the
fucosyltransferases (PF00852) and the G-protein coupled receptors
(PF00001, PF00002 and PF00003) were downloaded from Schisto-
soma mansoni GeneDB [25], assembly version 4. Intra-family nucleic
acid sequences were assembled into contigs and singletons accord-
ing to the default parameters of SeqMan within the DNASTAR
Lasergene application software. DNA microarray oligonucleotides
mapping to each representative contig/singleton were identified
(when possible) and normalised AF647 intensity units were
extracted. Heatmaps were generated (Spearman’s rank, average
linkage clustering) for each gene family allowing gene expression
values to be visualised for each member across the schistosome
lifecycle.
Real time reverse transcription (RT) - PCR analysis
The transcript abundance of each selected mRNA was quantified
relative to alpha tubulin in eight stages (triplicate measurements) of
the S. mansoni lifecycle using real-time RT-PCR analysis as previously
described [30]. Reactions were performed on a MiniOpticon real-
time PCR thermal cycler system (Bio-Rad) using iQ SYBR Green
Master Mix (Bio-Rad) according to the manufacturer’s instructions.
The amplification efficiency (E) of each primer set was determined
during assay development by plotting the cycle thresholds (Ct) from
serial dilutions of a suitable cDNA sample and inputting the resulting
slope in the equation, E=10(21/slope). For each real-time PCR
reaction the following equation was used to calculate a normalised
SmGeneX expression ratio:
ratio~ ESmAt1ð ÞCtSmAT1
.
ESmGenexð ÞCtSmGeneX
where ESmAt1 is the amplification efficiency of the reference gene
(alpha tubulin), ESmGeneX is the amplification efficiency of the target
gene, CtGeneX is the cycle threshold of the target gene and
CtSmAT1 is the cycle threshold of the reference gene from the same
cDNA sample. PCR oligonucleotide primer specifics are included in
Datasets S7–S9.
BLAST facilitated genome exclusion analysis
Two FASTA files were generated for iterative BLAST analysis;
one containing 612 sequences derived from 37 MCLs demonstrat-
ing transcription of genes in cercariae/schistosomula and/or
definitive host lifecycle stages (Dataset S6) and one containing 338
(manual removal of 17 low quality sequences from the original 355)
sequences derived from genes demonstrating less than 1%
variability (Dataset S5) in expression across the schistosome lifecycle
(constitutively-expressed). These two FASTA files were subsequent-
ly subjected to the same three iterative BLAST analyses. First,
sequences were submitted to a BLASTn analysis against the S.
mansoni shotgun reads collected from the Wellcome Trust Sanger
Institute’s genome project [31] to insure that they were indeed
derived from schistosome material. Only those sequences displaying
E values less than 1e210 were retained. Secondly, the remaining
sequences were submitted to a BLASTx search of the non-
redundant protein databases to eliminate cross-genome orthologs
(hits demonstrating E values less than 1e205 were excluded). Finally,
the remaining schistosome sequences were submitted to a tBLASTx
search of the EST databases to further eliminate cross-genome hits
contained within high-throughput sequencing projects (hits dem-
onstrating E values less than 1e205 were excluded). Gene products
passing all three iterative BLAST criteria are included in Dataset S5
(constitutively-expressed transcripts) and Dataset S6 (developmen-
tally-regulated transcripts).
Results
Schistosoma lifecycle correlation analyses
This study details the transcriptional progression of schistosome
development using DNA microarray profiling and combinatorial
Schistosoma Transcriptional Profiling
www.plosntds.org 4 November 2009 | Volume 3 | Issue 11 | e543
bioinformatics involving statistical (pairwise comparisons)- and
network (graph clustering)- based data mining. Prior to bioinfor-
matics-led data mining, rigorous normalisation of the lifecycle
dataset was employed and M ratio (log2 (Alexafluor647/Alexa-
fluor555 intensities)) correlations investigated to determine rela-
tionships between replicate samples and lifecycle stages (Fig. 1).
Here, replicate expression values collected from DNA microarray
hybridisation of the same lifecycle stage were highly correlated,
with all but one adult female replicate demonstrating strong
correlations with the other replicate samples. This adult female
replicate was manually excluded from subsequent analyses.
However, the most important observation from these M ratio
correlation analyses was that, while most schistosome lifecycle
stages were to some degree transcriptionally correlated, there were
two striking exceptions. The egg (miracidium-producing) and the
daughter sporocyst (cercariae-producing) life-stages were found to
be outliers, demonstrating that each are transcriptionally distinct
when compared to all other schistosome developmental forms.
Schistosoma development characterised by pairwise
statistical analyses
The first approach in describing the transcriptional patterns
underlying schistosome development involved the identification of
differential gene expression calculated from a series of pairwise
comparisons between key lifecycle stages (Table 1 and Dataset S2).
We chose an adjusted p value (Adjp ,0.05), corrected using the
Benjamini & Hochberg method for multiple testing [32], to identify
differentially expressed genes between the paired comparisons.
Using this criterion, nineteen different comparisons were performed
with a total of 1,313 (973 non-redundant) gene products differ-
entially expressed. Many of the differentially expressed transcripts
confirmed patterns identical to those previously reported. For
example, S. mansoni venom allergen-like molecules (SmVALs) 3
(CONTIG4696 and AI395850, Smp_193710) and 9 (CD111828,
Smp_176180) were confirmed as differentially expressed in the
snail-residing schistosome stages compared to mouse-residing
parasite forms whereas SmVAL7 (SMLC15A11A, Smp_070240)
and SmVAL13 (CONTIG2212, Smp_124060) displayed the
opposite trend [30]. Other genes differentially expressed in this
specific paired comparison (intra-snail vs. intra-mouse, Table 1) are
likely to include transcripts associated with the biology of the
digenetic state. Loosening of this strict statistical criterion (Adjp
,0.05) identified additional gene products differentially expressed
in all of the pairwise comparisons performed (Table 1 and Dataset
S2). Many of these comparisons may be useful in staging (i.e.
defining age) schistosome development.
Collective visualisation of all 973 non-redundant differentially
expressed gene products (Dataset S3) as a heatmap illustrated
three major patterns of transcription: 1) genes expressed
predominantly in the vertebrate dwelling schistosome life-stages
(definitive host-enriched, Fig. 2A, clade I), 2) genes primarily
expressed in the snail dwelling schistosome life-stages (intermediate
host-enriched, Fig. 2A, clade II) and 3) genes mainly expressed in
adult parasites (female- or male- enriched, Fig. 2A, clade III). This
was not surprising as these patterns associate with the major
biological features of the schistosome’s lifecycle; digenesis and
dioecy. Further filtering of this dataset to include only transcripts
that additionally contain a greater than 32-fold differential
expression (in at least one pairwise comparison) revealed the most
developmentally regulated schistosome genes across the parasite’s
lifecycle (Fig. 2B and Dataset S3). These 448 transcripts included
an aquaporin (aquaporin-3: Contig45, Smp_005720), a lecithin-
cholesterol acyltransferase (LCAT: Contig5322, Smp_160880),
an endothelin-converting enzyme (neprilysin-2: CONTIG5730,
Smp_171100), a putative aromatic amino acid decarboxylase
(CD078685, Smp_135230) and a S. mansoni mRNA encoding a
Ser- and Thr- rich mucin-like protein (SMSERTHRP,
Smp_149610) containing a C-type lectin domain. Interestingly,
four well-studied gene families were also highly enriched within
this developmentally-regulated dataset; the previously mentioned
SmVALs (unknown function [30]), the tetraspanins (putative
vaccine candidates [18]), the tegument-associated antigens (asso-
ciated with resistance to re-infection in human populations [33])
and the cathepsin B/Ls (involved in proteolytic biology of schis-
tosome haematophagy [34]).
While pairwise analysis of transcriptional data collected from
numerous parasite lifecycle stages generated a wealth of
information related to schistosome developmental biology, a
cohort of constitutively expressed gene products was also
uncovered in our analyses. Here, gene product open reading
frames (ORFs) that displayed the lowest 1% variation in
expression across the schistosome lifecycle were interrogated for
Gene Ontology (GO) term enrichment (Fig. 3 and Dataset S5).
The majority of these constitutively expressed gene products were
highly transcribed (Fig. 3A) and have GO term annotations that
place their putative functional role in the fundamentally important
‘house-keeping’ processes of metazoan life (Fig. 3B–D). S. mansoni
alpha tubulin (SCMSAT1A, Smp_103140), a gene product used
extensively as a reference for quantitative reverse transcription
PCR analyses [16,30,35,36,37,38,39], was found within this
dataset. Forty-one constitutively expressed gene products specific
to the phylum Platyhelminthes (as determined by the BLAST
criteria within the Methods), and thus potential drug or vaccine
candidates, were also identified in this analysis (Dataset S5).
Network analysis of schistosome development
To complement the above-described pairwise analyses, we
additionally performed a network investigation of gene expression
across the schistosome’s lifecycle. Briefly, network analysis
(comprised of graphs created by nodes and edges) allowed the
position of each schistosome transcript (nodes) to be placed within
the context of all other differentially expressed transcripts (edges)
throughout the parasite lifecycle. Pearson correlations between the
normalised AF647 intensity values (Dataset S4) of every gene were
generated and the data matrix (correlation threshold of r = 0.94)
was used to interrogate the schistosome lifecycle. The stored data
were used to draw the edges (lines) between nodes (transcripts) in
network graphs. Nodes sharing edges (relationships above the set
threshold) formed into identically coloured groups (graph
components). Connectivity between nodes determined the 3-
dimensional layout of the graphs. Using a Pearson correlation cut
off of r = 0.94, 16,621 nodes (containing 12,132 oligonucleotides)
formed graph components. One particular graph component
containing two clusters of co-regulated genes (I: egg and II:
Daughter sporocyst lifecycle stages) is illustrated (Fig. 4A).
Large graphs were further subdivided into groups, or clusters of
nodes, using a Markov Cluster algorithm (MCL). MCL clusters
included transcripts that were statistically differentially expressed
across groups (i.e. Adjp-value ,0.05) as well as those that,
although exhibiting similar profiles, were not statistically signifi-
cant (examples in Figs. 5 and 6). This type of analysis, therefore,
allowed for statistical associations to be verified, and was capable
of identifying associations which statistical analyses (on minimally
replicated datasets) could not detect. MCL clustering applied to
this dataset at a stringency of 1.7 identified 387 clusters (MCL1-
387) of 6 or more nodes displaying differential gene expression
across the schistosome lifecycle (i.e. 12,132 nodes or 73% of the
original dataset, Fig. 4A and Dataset S6).
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Figure 1. Egg and daughter sporocyst parasite stages display the most divergent transcriptional profiles within the Schistosoma
lifecycle. Correlations of M (log2 (Alexafluor647/Alexafluor555)) ratio values between intra- (lifecycle replicate) and inter- (life-stage comparison)
parasite samples were calculated. A heatmap of the correlations, calculated on data normalised within each DNA microarray, is illustrated. Red
represents a high correlation and blue depicts a low or lower correlation. Un-scaled data were clustered by Euclidean distance and shown as
dendrograms above and to the left of the heatmap. * Indicates female sample replicate manually removed.
doi:10.1371/journal.pntd.0000543.g001
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Figure 2. Clusters associated with the schistosome digenetic and dioecious states are the most statistically significant
transcriptional patterns identified. Normalised and p value corrected data (see Methods) were used to generate statistically significant gene
lists (Table 1, Datasets S2 & S3). A) A heatmap of differentially expressed genes significant at an adjusted p value of ,0.05 in at least one bimodal life
stage comparison is illustrated (red – highly expressed, blue – weakly expressed). Log2 intensity values were clustered by Euclidean distance and
shown as a dendrogram on top of the heatmap. Three major clusters are identified (I – expressed predominantly in the definitive host, II – expressed
predominantly in the intermediate host and III – expressed differentially between the adult sexes). B) Specific examples of some transcripts found in
each of the three major clusters additionally showing .32-fold differential expression (DE) in at least one bimodal life-stage comparison. A full list of
transcripts showing.32 fold DE in at least one bimodal life-stage comparison is found in Dataset S3. Bar graphs represent average normalised AF647
intensity values (Dataset S4) for the chosen transcripts. Array ID represents unique 50-mer oligonucleotide identifier on the DNA microarray (list of
parent sequences where 50-mer oligonucleotide was designed is found in Dataset S1); BLASTx ID represents name of closest match to parent
oligonucleotide sequence in NCBI database; SchistoGeneDB ID represents gene model (version 4.0) identifier of the mapped 50-mer oligonucleotide.
doi:10.1371/journal.pntd.0000543.g002
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Figure 3. A cohort of constitutively expressed gene products is identified from DNAmicroarray analysis of the Schistosoma lifecycle.
Normalised log2 AF647 intensity data were used to identify gene products constitutively expressed throughout the schistosome lifecycle (Dataset S5).
A) Heatmap of transcripts exhibiting the lowest levels of variation (1% variation across lifecycle). Log2 intensity values were clustered by Euclidean
distance and shown as a dendrogram to the left of the heatmap (red – highly expressed, blue – weakly expressed). Specific examples of gene
products constitutively expressed are illustrated (full list included in Dataset S5). B–D) Oligonucleotide sequences (Array ID) mapping to specific S.
mansoni gene models (version 4.0) in SchistoGeneDB were analysed for Gene Ontology enrichment (p,0.01) using a hypergeometric test. B)
Biological process enriched terms; C) Molecular function enriched terms and D) Cellular component enriched terms.
doi:10.1371/journal.pntd.0000543.g003
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Figure 4. Network analysis of the schistosome lifecycle identifies egg and daughter-sporocyst enriched transcripts. Network analysis
was performed as described in Methods using the BioLayout Express3D package [29]. A) One network graph component containing two major clusters
is illustrated (I; egg enriched transcripts and II; daughter sporocyst enriched transcripts). Different Markov clusters (MCL) within the network are
represented by different coloured nodes (genes). The network analysis was performed using a Pearson correlation of r = 0.94 and Markov cluster
stringency of 1.7 with accompanying details indicated. Nodes included in the identified 387 MCLs are included in Dataset S6, and form the basis of all
subsequent descriptions. B) MCL1 includes transcripts highly enriched in the egg lifecycle stage (I). Some representative MCL gene examples are
provided in addition to the GO terms significantly enriched in this cluster. C) MCL2 contains transcripts highly enriched in the daughter sporocyst
lifecycle stage (II). Some representative MCL gene examples are provided. Bar graphs represent average normalised AF647 intensity values (Dataset
S4) for all transcripts in that cluster, with replicate values obtained from independent life-stage hybridizations indicated as identical colours.
doi:10.1371/journal.pntd.0000543.g004
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Figure 5. Markov clustering expands the repertoire of differentially expressed transcripts associated with the schistosome
dioecious and digenetic state. Network analysis was performed as described in Methods (Pearson correlation, r = 0.94 and Markov cluster
stringency = 1.7). Selected MCLs are included to illustrate transcripts enriched in the intermediate host (A, MCL9), definitive host (B, MCL69) or in
adult male and female schistosomes (C, MCL7 - Male. Female; MCL12 - Female.Male). In each case, specific examples of transcripts included in the
selected MCLs are listed (full list of transcripts included in each cluster is found in Dataset S6). Enriched Gene Ontology Molecular Function categories
are also included where identified. Bar graphs represent average normalised AF647 intensity values (Dataset S4) for all transcripts in that cluster, with
replicate values obtained from independent life-stage hybridizations indicated as identical colours.
doi:10.1371/journal.pntd.0000543.g005
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Figure 6. The minichromosome maintenance (MCM) heterohexamer is coordinately expressed in both mother sporocysts and 3-
week adult worms. A) MCL190 identified 9 gene products sharing a peak of gene expression in the mother sporocyst and 3-wk adult worms. Bar
graphs represent average normalised AF647 intensity values (Dataset S4) for all transcripts in MCL190, with replicate values obtained from
independent life-stage hybridizations indicated as identical colours. B) List of genes contained within MCL190 demonstrates the presence of 4 out of
the 6 transcripts constituting the eukaryotic MCM heterohexamer. C) Heatmap (Spearman’s rank correlation coefficient, average linkage clustering,
red – highly expressed, blue – weakly expressed) of all 6 MCM heterohexamer subunits (Dataset S10, including two MCM2 paralogs) defined by both
array and GeneDB identifiers (ID). * indicates three MCM transcripts not clustered within MCL190. D) Scatterplot of MCM heterohexamer normalised
AF647 intensity units in mother sporocyst versus 3-wk worm samples. A correlation coefficient of 0.738 suggests coordinated expression of the MCM
heterohexamer with individual outliers (Smp_054840 and Smp_037590) indicated.
doi:10.1371/journal.pntd.0000543.g006
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Within the representative graph component (Fig. 4A), MCL
analysis identified two major clusters that were highly enriched for
egg and daughter sporocyst transcripts (MCL1 and MCL2, Fig. 4B
and 4C, respectively). Within the egg-enriched dataset, 3,522 gene
products were identified, of which IPSE/alpha-1 (AY028436.1,
Smp_112110), fizzled-5 (CD201642, Smp_139180) and omega-1
(CD098221, no corresponding Smp) were members. As both
IPSE/alpha-1 and omega-1 were previously identified as being
expressed only in the egg stage of schistosome development
[40,41], the remaining gene products contained within MCL1 are
likely to shed additional light on the biology of this immunopath-
ogenic lifecycle stage. Gene ontology analysis of egg-associated
transcripts contained within MCL1 (Fig. 4B) additionally suggest-
ed that processes involving microtubules and the cytoskeleton were
highly enriched here. Investigation of the transcripts enriched
within the daughter sporocyst stage (Fig. 4C and Figure S6)
uncovered 1,509 gene products associated with this particular
intramolluscan, schistosome developmental form. Interestingly,
55% (834/1,509) of these daughter sporocyst enriched transcripts
had no known sequence similarity in NCBI databases (currently
annotated as unknown or hypothetical proteins). Within sequences
that have database hits, a rhodopsin-like GPCR (SmRHO [42]:
Contig2175, Smp_104210) and a DNA helicase (DDX11
ortholog: CD074196, Smp_130210) were identified. As very few
of these daughter-sporocyst enriched transcripts could be mapped
to SchistoGeneDB (via their 50-mer long oligonucleotide repre-
sentations, see Methods), no corresponding Gene Ontology
classifications (similar to that performed for the egg enriched
transcripts) could be identified.
Examination of the remaining 385 MCLs revealed clear
examples of stage-specific gene expression, with network analysis
being very good at teasing apart developmentally-regulated
transcription in all three environmental niches occupied by the
schistosome (intermediate host, vertebrate host and freshwater).
While it is impossible to illustrate all of these clusters here (full list
included in Dataset S6), a few examples (Figs. 5 & 6) will be
described. Gene products contained within MCL9 represented
those schistosome transcripts preferentially expressed in the
lifecycle stages interacting with the intermediate host (Fig. 5A).
While 122 of the 141 transcripts identified here were also found
using pairwise statistical comparisons (Adjp ,0.05, Table 1,
Fig. 2A and Datasets S2 & S3), 19 gene products were newly
discovered. Interestingly, one of these products (Dyp-type
peroxidase: CONTIG13207, Smp_160550) is a member of a
recently reviewed atypical heme peroxidase family [43] that
appears to be expanded within the Platyhelminthes and not
present within vertebrates [8].
MCL69 contains schistosome transcripts (Fig. 5B) predomi-
nantly expressed in life-stages interacting with the definitive host
(as do MCL42, MCL210 and MCL259, see Dataset S4). The
majority of these 18 transcripts (17/18) were also identified by
pairwise analyses (Adjp,0.05, Table 1, Fig. 2A and Datasets S2 &
S3), providing a clear example of how two different bioinformatics
approaches led to the identification of identical stage-associated
information (with SmTSP2 [18]: AF521091.1, Smp_181530 and
Sm29 [44]: AF029222, Smp_072190 representing examples).
Analysis of transcripts clustered within MCL7 and MCL12,
however, revealed the full capability of network analysis by
identifying additional genes associated with the adult dioecious
state (Fig. 5C). Here, 129 further transcripts were identified as
being male-associated in the adult (195 total with 66 previously
identified by pairwise comparisons, Adjp ,0.05, Table 1, Fig. 2A
and Datasets S2 & S3) and 47 new transcripts found to be
predominantly expressed in the adult female schistosome (93 total
with 46 previously identified by pairwise comparisons, Adjp
,0.05, Table 1, Fig. 2A and Datasets S2 & S3). Examples of
specific network identified transcripts within these clusters are
illustrated (Male - myosin II: SmMIIHC, Smp_085540; prolyl-4-
hydroxylase alpha subunit: CONTIG7859, Smp_068280; colla-
gen alpha 2 (I): Contig1304, Smp_164590 and Female – tyrosinase
2: CONTIG1812, Smp_013540; eggshell protein: AI975086,
Smp_191910; diacylglycerol acyltransferase 2: Contig1301,
Smp_178950)). Corresponding GO enriched Molecular Function
categories within the adult male (MCL7) and female (MCL12)
clusters confirmed well-documented functional differences [38]
between the adult sexes. Here, adult male schistosomes displayed
an enrichment of transcripts involved in structural biology whereas
adult female parasites contain increased transcript representation
within oxidoreductase, glutamate-5-semialdehyde dehydrogenase,
glutamate 5-kinase and phosphotransferase activities (Fig. 5C).
While the network analysis was capable of detecting additional
transcripts displaying developmental expression (when compared
to the datasets generated by pairwise comparisons, Datasets S2 &
S3), this approach was also able to identify new clusters of
developmentally regulated transcripts that were not detected by
statistical analyses. One example is MCL190 (full list can be found
in Dataset S6), which included two peaks of expression; one in the
asexually proliferating, mother sporocyst stage and one in the
sexually maturing, 3-wk adult schistosome stage (Fig. 6A).
Interesting, all transcripts within this cluster are involved in
eukaryote DNA replication processes (except the hypothetical
protein, CD184201, no Smp, Fig. 6B and Figure S10) with four of
the six essential DNA helicase subunits ([45] MCM, minichromo-
some maintenance subunits 2, 5, 6 and 7) included. Searching
SchistoGeneDB [25] for the remaining two components of the
core MCM heterohexamer (MCM3, Smp_037590, CON-
TIG5269; MCM4, Smp_172530, CD127885) also revealed a
second MCM2 gene prediction (Smp_054840, Contig565, possi-
bly suggestive of an ‘unusual MCM’ as previously described [45]).
While these schistosome MCMs were found outside MCL190, a
heatmap representation of all MCM transcripts revealed the co-
expression of the heterohexamer in both mother sporocyst and 3-
wk parasite lifecycle stages (Fig. 6C), which was highly correlated
(r = 0.738, Fig. 6D).
Identification of developmentally regulated,
Platyhelminthes-specific, schistosome transcripts
Schistosome genes expressed predominantly in the invading
cercariae, tissue migrating schistosomula and/or blood residing
worms are likely to participate in host immunomodulation, host
immunoevasion and establishment of long-term, copulating,
dioecious partners. We were interested in identifying those gene
products, expressed in these particular lifecycle stages, which had
no significant sequence similarity (see Methods for criteria) to NCBI
database entries outside the phylum Platyhelminthes. These
products would, therefore, represent another pool of attractive
targets for anti-schistosome intervention strategies. We selected 37
MCLs (7, 35, 37, 38, 42, 45, 46, 65, 69, 77, 79, 94, 135, 171, 177,
183, 185, 187, 210, 214, 221, 222, 223, 259, 285, 287, 299, 301,
304, 319, 326, 336, 337, 338, 340, 348 and 350) as the 612
transcripts included herein displayed the queried transcriptional
profile (expression in cercariae to schistosomula transformation
and/or continued expression into the adult stage). A combined
series of BLAST queries led to the identification of 294 gene
products that only contained significant sequence similarities to
schistosome or other Platyhelminth species. A heatmap represen-
tation (and oligonucleotide ID) of these 294 transcripts’ normalised
mean fluorescent intensities is depicted in Dataset S6.
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Global expression profiling of specific schistosome gene
families
This DNA microarray characterisation of the schistosome
lifecycle, as described by two different data analysis methodologies,
provided a rich resource for novel biological discoveries. However,
global profiling of the schistosome lifecycle additionally allowed for
transcriptional comparisons of individual members within specific
gene families to be conducted. Transcriptional ‘snapshots’ can
provide important evidence for the selection/rejection of gene
family members in the context of novel vaccine candidate or drug
target identification and characterisation, saving valuable time in
the pipeline of schistosomiasis control initiatives. We focused our
analysis on three major gene families: fucosyltransferases (enzymes
responsible for producing many of the immunomodulatory
structures during infection [20]), tetraspanins (proteins that
contain 4 transmembrane domains and are capable of inducing
protective anti-schistosomal immunity [18]) and GPCRs (proteins
that contain 7 transmembrane domains and are the most common
targets of all clinically prescribed drugs [19]). We used PFAM
[46] searches of SchistoGeneDB [25] to identify all predicted
schistosome gene products within each family (PF00852 –
fucosyltransferases; PF00335 – tetraspanins; PF00001, PF00002
and PF00003 – GPCRs). Clustering of all representative intra-
gene family members provided a non-redundant list of schistosome
fucosyltransferases (Dataset S7), tetraspanins (Dataset S8) and
GPCRs (Dataset S9) to facilitate individual gene expression
comparisons across the lifecycle. It is clear from the generated
heatmaps of normalised mean fluorescent intensities that quite
distinct gene expression profiles were identified within each gene
family (Fig. 7). Expression profiles associated with the fucosyl-
transferase gene family were split between those members
transcribed only in post-schistosomula stages compared to those
members expressed in both snail-residing and mouse-residing
parasite lifecycle stages (Fig. 7A). In contrast, the tetraspanins
(Fig. 7B) and GPCRs (Fig. 7C) collectively displayed more diverse
transcriptional patterns, possibly indicating complex stage-specific
roles associated with individual family members. Real time
quantitative PCR was used to verify the expression of several
fucosyltransferase (Fig. 7D), tetraspanin (Fig. 7E) and GPCR
(Fig. 7F) family members across the schistosome lifecycle.
Discussion
Successful interrogation of large transcriptomic datasets de-
pends upon appropriate analysis and bioinformatics tools to
facilitate the effective bridging of phenotypic discovery to
functional application. Within the field of schistosomiasis, large
transcriptomic databases are being routinely created due to the
current availability and use of several long-oligonucleotide DNA
microarrays [13,14,16,38]. This trend will continue as soon as
high-throughput sequencing platforms become financially more
accessible to academics and the use of these platforms is no longer
restricted by the bottleneck of current computational sequence
assembly algorithms. However, all high-throughput technologies
require the most effective strategies for elucidating biologically
meaningful information from complex transcriptome datasets.
Towards this end, we describe a combinatorial bioinformatics
strategy for analysing transcriptome data collected from the
hybridisation of 15 different schistosome lifecycle stages, spanning
three unique environmental niches and two distinct hosts, to a
long-oligonucleotide DNA microarray consisting of 37,632
elements.
Initial analyses of normalised fluorescent DNA microarray data
collected from the schistosome lifecycle immediately illustrated a
high degree of correlation, in all but two cases, across the 15
profiled developmental forms (Fig. 1). This suggested that, while
clear stage and sex-specific transcriptional differences can be
identified (Figs. 2 and 4–7), many schistosome transcriptional
processes are coordinately regulated to a degree, independent of
the environmental niche that the parasite occupies. Interestingly,
transcripts from both the short-lived cercariae and miracidia
lifecycle stages had highly correlated, normalised fluorescent
intensities when compared to those collected from any of the
long-lived adult parasite life stages (e.g. 2-wk, 3-wk, 5-wk or 7-wk
mixed-sex schistosomes). This indicated that the infective lifecycle
stages are not as transcriptionally silent as previously perceived [4]
or, equally possible, that they are able to stably store a large
repertoire of transcripts important for infection and lifecycle
progression [47]. Additionally, this correlation analysis demon-
strated that the transcriptional profiles collected from egg and
daughter sporocyst lifecycle stages were outliers when compared to
other schistosome developmental forms. Classical studies of the
schistosome egg have clearly indicated that this lifecycle stage is
involved in complex biological phenomena including the induction
of host immunopathologies [48], and more important to our
results presented here, production of snail-infective miracidia. As
miracidia development within the egg progresses through five
morphologically distinguishable stages (Stages 1–5, as described by
Vogel [49]) and the egg material used in this study included all
five, it is likely that lack of correlation to other developmental
forms was directly linked to the biological intricacy of egg
maturation. Transcriptional profiling of fractionated egg samples
[50] will likely shed more light on the intricate biology of egg
maturation in future investigations. Similarly, the complex biology
associated with the daughter sporocyst, involving both sporocys-
togenesis and cercariogenesis [51], provides a rational explanation
for the lack of correlation observed between this developmental
form and others within the lifecycle. Therefore, simple correlation
analyses of normalised gene expression data collected across the
schistosome lifecycle provided an immediate insight into parasite
developmental biology and identified the two most transcription-
ally distinct developmental forms.
More detailed approaches, involving both pairwise and network
based transcriptomic analyses, were next used to interrogate
parasite lifecycle progression. Although pairwise analyses detected
stage and sex-associated gene products of statistical significance
(Table 1, Dataset S2), the inherent experimental background
found in large-scale microarray datasets, collected from minimally
replicated experiments (due to difficulties in obtaining schistosome
material), forced the use of multiple testing corrections to limit
false positive identification. While this restricted our analysis to
973 gene products differentially expressed in at least one pairwise
comparison (Fig. 2A), the dataset was deemed to be a robust and
strictly-selected representation of schistosome developmental
biology. It is likely that the use of alternative statistical methods
for transcriptome analysis (e.g. ANOVA) would generate comple-
mentary datasets of schistosome development. This was beyond
the scope of the current study, but could be revisited using primary
data deposited within EBI ArrayExpress [28].
The ease by which statistical methods identified the most
transcriptionally divergent points in the schistosome lifecycle, namely
those related to the dioecious and digenetic state (Fig. 2A and
Dataset S3), was readily apparent. While many of these develop-
mental and sex-associated transcriptional profiles supported previous
observations (e.g. cathepsin B, Contig1226 [52] and superoxide
dismutase, SCMSOD1 [37,38,53]), we uncovered a variety of
additional transcripts (e.g. netrin: CD167333, Smp_146840;
the netrin receptor: CD168439, Smp_165440; leishmanolysin:
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Figure 7. Analysis of three important schistosome gene families reveals differential transcription of individual members across the
parasite’s lifecycle. Using the latest version of the schistosome genome assembly (version 4.0), all putative fucosyltransferase- (PF00852, Dataset
S7), tetraspanin- (PF00335, Dataset S8) and GPCR- (PF00001, PF00002 and PF00003, Dataset S9) family members were identified. DNA microarray
oligonucleotides were mapped to specific regions of the predicted genes using the S. mansoni genome browser function of S. mansoni GeneDB [25].
For those predicted gene family members where 50-mer oligonucleotides could be mapped, expression data was extracted and analysed. Heatmap
representation of all S. mansoni: A) fucosyltransferases (PF00852), B) tetraspanins (PF00335) and C) GPCRs (PF00001, PF00002 and PF00003)
differentially expressed across the parasite’s lifecycle (all data included in Datasets S7–9. Heatmaps (red – highly expressed, blue – weakly expressed)
were created from normalised AF647 intensities using a Spearman’s rank correlation coefficient and average linkage clustering (Methods).
Corresponding real time RT-PCR confirmation of selected family members (*) (D – fucosyltransferases: CD154939/Smp_054300 & AF183577/
Smp_148850; E – tetraspanins: CD148755/Smp_176870 & CD069616/Smp_155310; F – GPCRs: CONTIG2914/Smp_128940 & CD098416/Smp_099670)
is indicated to the right of heatmap.
doi:10.1371/journal.pntd.0000543.g007
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CONTIG7854, Smp_173070; CD164149, Smp_173070; CON-
TIG7744, Smp_173070; and CD133033) that displayed differential
expression across the schistosome lifecycle (full list in Dataset S3).
Effectively, these transcripts (particularly those also displaying .32
fold differential expression, Fig. 2B and Dataset S3) represent the
highest quality dataset, to date, that accurately describes parasite
transcriptional patterns across three environmental niches. As
performed recently for neuronal cell cultures [54], it would be
interesting to identify the presence of conserved transcriptional
regulatory features (i.e. amongst promoters or untranslated regions
(UTRs) of coordinately expressed genes) within this developmental-
ly-regulated dataset. While this was outside the scope of the present
study, such information could lead to advances into the mechanisms
underpinning gene expression regulation between the adult sexes or
across developmental stages of this platyhelminth.
The co-regulation of both netrin and netrin receptor during
sexual maturation in the definitive host (peaking in 5 wk and 3 wk
adult worms, respectively) is noteworthy as this receptor/ligand
interaction is absolutely essential for somatic and gonadal
development in Caenorhabditis elegans [55] as well as central nervous
system (CNS) regeneration in Schmidtea mediterranea [56]. Inhibiting
netrin/netrin ligand interaction may negatively influence schisto-
some sexual maturation and CNS development, thus providing an
opportunity for intervention. The inverse developmental regulation
of three putative, cell-surface leishmanolysin-like proteases (two
intermediate host-enriched isoforms: CONTIG7854, CD164149
and CONTIG7744 and one definitive-host enriched isoform:
CD133033) is also notable due to their proposed functional roles
in parasite invasion mechanisms and immune evasion strategies
[57]. During leishmaniasis, leishmanolysin-like proteins are in-
volved in inactivation of complement C3 [58], inhibition of host cell
interactions [59], perturbations in host cell signaling [60] and
degradation of the extracellular matrix [61]. It is tempting to
speculate that the schistosome leishmanolysin-like orthologs impart
analogous activities during host/parasite interactions within snails
and vertebrates, collectively favouring the development of schisto-
somiasis. Indeed, secreted/excreted leishmanolysin-like proteins
have recently been reported during cercariae/schistosomula [62]
and miracidium/mother sporocyst [63] transformation and pro-
vides evidence for this hypothesis. Inverse lifecycle expression of
duplicated gene family members has been observed for the
SmVALs and probably represents the schistosome’s evolutionary
solution for niche specialization as has previously been described
[30]. As these leishmanolysin-like proteases represent another
expanded gene family (along with the Dyp-type peroxidases,
Fig. 5A) within the Schistosoma (orthologs not present in vertebrate
genomes), targeting members expressed in key life-stages could lead
to the selective development of novel intervention strategies.
Statistical analyses also made it straightforward to identify those
schistosome gene products that were constitutively expressed
across the parasite’s lifecycle. Here, we examined the lifecycle
dataset for transcripts that did not display differential expression in
any pairwise comparison and further selected only those
individuals that exhibited invariant (less than 1% variation)
normalised fluorescent intensities in each lifecycle stage (Fig. 3).
This analysis identified 338 ‘housekeeping’ gene products (709
with less than 2% variation, data not shown), which expands the
number of schistosome transcripts considered to be absolutely
essential for lifecycle progression. While many of these transcripts
were linked to conserved biological activities essential for
metazoan life (Fig. 3B–D), 41 gene products displayed no sequence
similarity outside of the Platyhelminthes (Dataset S5) and, thus
could be considered as a pool of novel anthelmintic targets. This
approach in drug target identification is in direct contrast to that
proposed by Caffrey et al. [64]. However, it is likely that both
methodologies will lead to significant progress in therapeutic
discovery and therefore, further characterisation of these Platy-
helminthes-associated, constitutively-expressed, schistosome gene
products is ongoing.
Since traditional pairwise comparisons of DNA microarray
datasets do not take into account the higher order structure of the
compared entities, it was impossible to determine how each
schistosome transcript interacted with its neighbours using this
statistical methodology. As network analysis examines large-scale
DNA microarray datasets quite differently [17,65,66,67,68], we
applied this complementary approach in transcriptome analysis to
the schistosome lifecycle. This permitted formation of higher order
structures within the dataset, effectively considering how each
schistosome transcript interacted with all other neighbouring
transcripts across the 15 lifecycle stages. Smaller distances of edges
between nodes represented highly correlated gene expression,
whereas larger distances of edges between nodes represented
poorly correlated gene expression (e.g. Fig 4A). Markov Clustering
algorithms (MCLs, [17,69]) subsequently were used to subdivide
large network graphs into clusters of co-regulated schistosome
genes (Figs. 4B–D, Fig. 5, Fig. 6 and Dataset S6).
While the parameters used for the network analysis were strict
(Pearson correlation, r = 0.94, Fig. 4A), 16,621 oligonucleotides
still passed these criteria. MCL analysis clustered 12,132 of these
oligonucleotides (72%) into 387 groupings (with at least 6
oligonucleotides/MCL cluster, Dataset S6) and this dataset was
subjected to further investigations. Many patterns of differential
gene expression (containing genes previously identified by the
statistical-based approaches used herein) were confirmed by
network analysis (intermediate-host enriched, Fig. 5A; definitive-
host enriched, Fig. 5B and adult sex-associated, Fig. 5C).
Revealingly, within these clusters were additional genes, harbour-
ing identical patterns of co-expression, which were not detected by
the statistical-based approaches (full list in Dataset S6). Further-
more, network-based techniques facilitated the discovery of key
life-stage associated transcripts (e.g. egg-associated, Fig. 4B;
daughter sporocyst-associated, Fig. 4C), which were not revealed
by statistical-led approaches leading to a more complete view of
schistosome developmental biology. As an example, the biphasic
up-regulation of four out of the six core, eukaryote DNA helicase
subunits (MCM2, 5, 6 and 7) in mother sporocysts and 3-wk
worms clearly indicated that these two lifecycle stages are more
heavily involved in DNA replication processes than any other
examined schistosome developmental form (MCL190, Fig. 6A–B).
Interestingly, MCMs have been implicated in other activities
including transcriptional regulation, chromatin remodeling and
checkpoint responses [45]. Mother sporocysts are actively involved
in asexual reproduction of the germinal cell-containing daughter
sporocysts within the intermediate host and 3-wk worms are
beginning to develop the gamete-producing organs (ovaries and
testes) required for sexual reproduction within the definitive host.
Therefore, this transcriptional finding has a biological rationale
and may point to these two life-stages as being critical checkpoints
in schistosome lifecycle progression. The important point here is
that network exploratory processes, and not standard statistical
methods, identified these MCMs (and MCM3 and 4, Fig. 6C–D
and Dataset S10) as being co-regulated.
Further interrogation of the network data led to the identifica-
tion of 37 MCLs predominantly expressed in the definitive host
interacting cercariae and/or schistosomula and/or adult develop-
mental stages (612 transcripts contained within MCLs 7, 35, 37,
38, 42, 45, 46, 65, 69, 77, 79, 94, 135, 171, 177, 183, 185, 187,
210, 214, 221, 222, 223, 259, 285, 287, 299, 301, 304, 319, 326,
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336, 337, 338, 340, 348 and 350). Included in these MCLs were
many schistosome gene products that display strong sequence
similarity to NCBI database entries collected from a wide range of
taxonomic groups. While these specific, annotated products were
of general interest in terms of developmental biology, there were
294 schistosome transcripts, which shared little or no sequence
similarity to NCBI entries outside of the phylum Platyhelminthes
(Dataset S6). These specific transcripts may complement those
similarly identified constitutively expressed schistosome gene
products (Fig. 3 and Dataset S5) and collectively be considered
paramount in the search for novel anti-schistosomal therapeutic
targets. Indeed, this genome exclusion approach is currently being
used for the identification of novel anti-fungal and anti-
trypanosomatid drug targets [70,71].
One final use of this large transcriptome dataset was to
comparatively profile individual members of important gene
families proposed as vaccine candidates, drug targets and
immunomodulatory enzymes. Firstly, this analysis (Datasets S7–
S9 and Fig. 7) implicates several new tetraspanins (PF00335, Tsps)
as vaccine candidates, based on the successful immunoprophylac-
tic results previously reported for the surface-exposed, tegumental
antigens SmTsp1 and SmTsp2 [18]. As both SmTsp1 and
SmTsp2 are predominantly expressed during cercariae to adult
worm development (Fig. 7B), other tetraspanins displaying this
transcriptional profile could be considered as novel immunopro-
phylactic targets. Based on the DNA microarray data (Fig. 7B and
Dataset S8), many tetraspanins meet this criterion including
CONTIG12733 (Sm04463) and Contig4768 (Smp_140000).
Interestingly, these two tetraspanins were also found localised on
the outer tegument (surface) of S. mansoni adults in a recent
proteomic investigation [72]. As the tegument is generally viewed
the most susceptible structure to host-mediated immune attack
[73], Sm04463 and Smp_140000 should be considered as priority
antigens in the search for novel vaccine candidates. The
localisation of the remaining tetraspanins will help guide a rational
strategy for future immunoprophylactic investigations of this
family.
Secondly, this analysis identified several schistosome G-protein
coupled receptors (GPCRs) as potential new drug targets (Fig. 7C).
GPCRs are 7-transmembrane domain spanning proteins constituting
the largest and most divergent class of cell surface receptor and are
among the most important of all drug targets: ,30% of all clinically
prescribed drugs function as GPCR agonists or antagonists [74].
GPCRs are therefore model drug targets and arguably amenable to
novel medical and biotechnology applications. The latest S. mansoni
genome assembly suggests that there are at least 65 non-redundant,
PFAM indicated, GPCR sequences (likely an under-representation,
see [9]) contained within the species (using PF00001, PF00002 and
PF00003 criteria, Dataset S9), including the molecularly charac-
terised histamine-responsive GPCR [75], the rhodopsin-like GPCR
[42] and a dopamine-reactive GPCR [76]. Unfortunately, the long-
oligonucleotide DNA microarray only contained unambiguous
representations for a fraction of these GPCRs (19/65 or 30%). As
GPCRs are generally expressed at much lower levels than most other
metazoan genes [77], their under-representation on our long-
oligonucleotide DNA microarray, developed predominantly from
EST sequence information collected up until May 2005 [16], was
therefore, not surprising. However, several examples of schistosome
GPCRs with drug-target potential were found, including represen-
tative members expressed during schistosomula development (e.g.
CD139742, Smp_149770; CD161155, Smp_152540 and CON-
TIG11889, Smp_127310) as well as those predominantly expressed
during adult worm maturation (e.g. CONTIG2914, Smp_128940;
CD081941, Smp_126890 and CD188997, Smp_161500). GPCR
ligand identification could lead to the characterisation of anti-
schistosome chemotherapeutic agonists/antagonists and is currently
being pursued using the application of automated robotics [78].
Finally, this approach was used to identify the transcriptional
profile associated with the schistosome fucosyltransferase (FucT)
repertoire (PF00852, Fig. 7A). This important protein family
enzymatically produces fucosylated glycolipids and glycoproteins,
which in turn are responsible for type-2 immune response
polarisation [79], circumoval granuloma formation [80] and
egg/endothelium interactions [81] during schistosomiasis. Primary
nucleotide similarity amongst schistosome family members is high
(14 Smp locations assembled into 8 clusters, Dataset S7) and,
therefore, only six oligonucleotides were useful for discriminating
individual FucT lifecycle transcriptional patterns. Interestingly,
FucT expression is divided into two major clades; those that are
expressed predominantly in miracidia/mother sporocyst stages
and those primarily expressed in sexually mature adults.
Expression of FucT subsets within the intermediate snail host
(CD154939, Smp_054300; CD064317, Smp_137730/
Smp_185720 and CD114628, Smp_137740) may well be
responsible for the distinctive fucosylation patterns exhibited by
larval glycoproteins, which are thought to function in immune
recognition by the snail’s defense system [82]. Conversely, FucTs
expressed in adult females and/or eggs (CD114628, Smp_137740;
CONTIG2407, Smp_109500 and CD127125, Smp099090) may
be responsible for the increased enzymatic activity detected in egg
extracts [20] as well as the major biological processes (type-2
response induction, circumoval granulomatous inflammation and
trans-endothelial migration) associated with schistosome eggs. If
so, then inhibiting (i.e. via iminosugars) these specific FucTs may
be a rational approach in preventing the formation of egg-
mediated pathological immune reactions [48] and, therefore, these
enzymes should be investigated as novel anti-schistosomal targets.
This study, combining network and statistical based analysis of the
S. mansoni lifecycle, has thoroughly explored many of the transcrip-
tional subtleties associated with developmental and sexual maturation
of this pathogenic trematode. As a novel approach in discovery-led
transcriptomics, these methods enabled a systems biology view to be
attained, with many possible immunoprophylactic and therapeutic
lead targets identified. It is envisioned that some of the candidates
identified herein will be subjected to future hypothesis-led functional
investigations. The completion of such specific examinations will
ultimately contribute to the successful development of novel control
strategies useful in the alleviation of schistosome-induced immuno-
pathologies, morbidities and mortalities.
Supporting Information
Dataset S1 Clustered sequences used for oligonucleotide design.
Complete nucleotide sequences of the clustered schistosome
dataset are provided. Clustering details are described in [16].
50-mer oligonucleotide representations of each sequence were
generated as described in [16].
Found at: doi:10.1371/journal.pntd.0000543.s001 (23.28 MB
TXT)
Dataset S2 Selected pairwise comparisons of schistosome
development. Multiple pairwise comparisons were performed as
described in the Methods. The column description worksheet
provides details as to each column header. Subsequent worksheets
identify transcripts passing the applied statistical criteria in the
lifecycle stages being compared.
Found at: doi:10.1371/journal.pntd.0000543.s002 (13.80 MB
XLS)
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Dataset S3 Lifecycle expression profiles of statistically identified
gene products from pairwise comparisons of key schistosome
developmental stages. The column description worksheet provides
details as to each column header. The remaining two worksheets
identify the transcripts passing the indicated statistical criteria
(‘adjp,0.05’ OR ‘adjp,0.05 and .32 FDE’ worksheets).
Found at: doi:10.1371/journal.pntd.0000543.s003 (1.78 MB XLS)
Dataset S4 Normalised AF647 fluorescent intensity values of
each oligonucleotide representation on the DNA microarray
across the schistosome lifecycle. Normalisation procedures are
described in the Methods. Replicate lifecycle stages are colour
coded. ‘Name’ column header represents the oligonucleotide
identifier. ‘Block, column, row and ID’ represent physical location
of each 50-mer oligonucleotide on the DNA microarray.
Found at: doi:10.1371/journal.pntd.0000543.s004 (33.74 MB
XLS)
Dataset S5 Schistosome transcripts demonstrating constitutive
expression. The column description worksheet provides details as
to each column header. Subsequent worksheets identify the
constitutively expressed transcripts (less than 1% variation in
expression across all life-stages examined, ‘constit_1pc_copy.txt’
worksheet), provide details as to Gene ontology (GO) enrichment
(‘constit_1pc_GO.xls’ worksheet) and list those that have sequence
similarity restricted within the Platyhelminthes (‘Platyhelminth
restricted’ worksheet).
Found at: doi:10.1371/journal.pntd.0000543.s005 (0.54 MB XLS)
Dataset S6 Identity of schistosome transcripts found by network
analysis within the 387 MCLs. The column description worksheet
provides details as to each of the column headers. Each subsequent
worksheet identifies transcripts found in each of the 387 MCLs and
also includes the average transcription profile (bar chart of replicate
values) of each MCL across the lifecycle. ‘MCLGO’ worksheet
provides details as to which MCLs have enriched GO classifications
included. ‘Develop Platyhelminth specific’ worksheet lists the
differentially-expressed transcripts, described in the Methods, that
only contain sequence similarity within the Phylum Platyhelmin-
thes. A heatmap of these identified transcripts is also included.
Found at: doi:10.1371/journal.pntd.0000543.s006 (28.62 MB
XLS)
Dataset S7 Expression profiles for all annotated fucosyltrans-
ferases (FucTs, PF00852) contained in the Schistosoma mansoni
GeneDB version 4 assembly. All FucTs nucleotide sequences were
downloaded from the Schistosoma mansoni GeneDB version 4
assembly and clustered according to the Methods. Details of this
assembly are included in the ‘FucT assembly’ worksheet. The
‘FucT’ worksheet provides the normalised expression profiles for
each FucT, where a 50-mer oligonucleotide could be mapped to
the genome assembly. The ‘FucT RTPCR’ worksheet provides the
details of FucT expression verified by real time PCR analysis. The
‘FucT for heatmap’ worksheet provides the average FucT
expression values used for construction of the lifecycle heatmap
depicted in Figure 7. All subsequent worksheets provide individual
FucT gene expression profiles for 50-mer oligonucleotides mapped
to Smp gene predictions.
Found at: doi:10.1371/journal.pntd.0000543.s007 (0.14 MB XLS)
Dataset S8 Expression profiles for all annotated tetraspanins
(tsps, PF00335) contained in the Schistosoma mansoni GeneDB
version 4 assembly. All tsp nucleotide sequences were downloaded
from the Schistosoma mansoni GeneDB version 4 assembly and
clustered according to the Methods. Details of this assembly are
included in the ‘tsp assembly’ worksheet. The ‘tetraspanins’
worksheet provides the normalised expression profiles for each
tsp, where a 50-mer oligonucleotide could be mapped to the
genome assembly. The ‘tsp RTPCR’ worksheet provides the
details of tsp expression verified by real time PCR analysis. The
‘Tsps for heatmap’ worksheet provides the average tsp expression
values used for construction of the lifecycle heatmap depicted in
Figure 7. All subsequent worksheets provide individual tsp gene
expression profiles for 50-mer oligonucleotides mapped to Smp
gene predictions.
Found at: doi:10.1371/journal.pntd.0000543.s008 (0.80 MB XLS)
Dataset S9 Expression profiles for all annotated GPCRs
(GPCRs, PF00001, PF00002 and PF00003) contained in the
Schistosoma mansoni GeneDB version 4 assembly. All GPCR
nucleotide sequences (separated for PF00001, PF00002 and
PF00003) were downloaded from the Schistosoma mansoni GeneDB
version 4 assembly and clustered according to the Methods. Details
of this assembly are included in the ‘GPCR assembly’ worksheet.
The ‘GPCRs’ worksheet provides the normalised expression profiles
for each GPCR, where a 50-mer oligonucleotide could be mapped
to the genome assembly. The ‘GPCRs RTPCR’ worksheet provides
the details of GPCR expression verified by real time PCR analysis.
The ‘GPCRs for heatmap’ worksheet provides the average GPCR
expression values used for construction of the lifecycle heatmap
depicted in Figure 7. All subsequent worksheets provide individual
GPCR gene expression profiles for 50-mer oligonucleotides mapped
to Smp gene predictions.
Found at: doi:10.1371/journal.pntd.0000543.s009 (0.39 MB XLS)
Dataset S10 Summary of expression data collected for the
schistosome minichromosome maintenance (MCM) heterohexa-
mer. Mapping of 50-mer oligonucleotide representations to genome
assembly version 4 of Schistosoma mansoni GeneDB. Average MCM
expression values used for construction of lifecycle heatmap in
Figure 6 are also included (‘MCM for heatmap’ worksheet).
Found at: doi:10.1371/journal.pntd.0000543.s010 (0.06 MB XLS)
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